(Q44800871)

6 December 2017

title

Withdrawal of cyclosporine or tacrolimus after addition of mycophenolate mofetil in patients with chronic allograft nephropathy (English)

1 reference

6 December 2017

1 reference

Barbara Suwelack

1

1 reference

6 December 2017

Ulf Gerhardt

series ordinal

2

1 reference

6 December 2017

Helge Hohage

series ordinal

3

1 reference

6 December 2017

language of work or name

English

0 references

publication date

1 April 2004

1 reference

American Journal of Transplantation

6 December 2017

published in

1 reference

6 December 2017

volume

4

1 reference

6 December 2017

issue

4

1 reference

6 December 2017

page(s)

655-662

1 reference

Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells

6 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

A long-term comparison of tacrolimus (FK506) and cyclosporine in kidney transplantation: evidence for improved allograft survival at five years

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Long-term impact of discontinued or reduced calcineurin inhibitor in patients with chronic allograft nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Treatment of chronic allograft nephropathy with mycophenolate mofetil after kidney transplantation: a Spanish multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Elective cyclosporine withdrawal 1 year after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Cyclosporin in therapeutic doses increases renal allograft vascular resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Long-term survival in renal transplant recipients with graft function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Inhibition of endothelial receptor expression and of T-cell ligand activity by mycophenolate mofetil

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Mycophenolic acid increases apoptosis, lysosomes and lipid droplets in human lymphoid and monocytic cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Mycophenolate mofetil decreases antibody production after cardiac transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

Nature and mediators of renal lesions in kidney transplant patients given cyclosporine for more than one year

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2004.00404.X

10.1111/J.1600-6143.2004.00404.X

21 January 2018

Identifiers

DOI

1 reference

6 December 2017

1 reference